1. Home
  2. LSB

as 07-26-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

NYSE

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The Company operates in China, the United States, Singapore, and the Philippines.

Founded: 2002 Country:
China
China
Employees: N/A City: N/A
Market Cap: 107.3M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 26.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $0.35 - $1.45 Next Earning Date: 08-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): -12.38% Revenue Growth (next year): 32.68%

LSB Daily Stock ML Predictions

Share on Social Networks: